The DOI matches its Crossref record; 339 of the 339 references it cites were found in a registry or an index.
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Open accessAbstract
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung cancer (15%) (SCLC). The 5-year survival rate for NSCLC patients remains very low (about 16% at 5 years). The two predominant NSCLC histological phenotypes are adenocarcinoma (ADC) and squamous cell carcinoma (LSQCC). ADCs display several recurrent genetic alterations, including: KRAS, BRAF and EGFR mutations; recurrent mutations and amplifications of several oncogenes, including ERBB2, MET, FGFR1 and FGFR2; fusion oncogenes involving ALK, ROS1, Neuregulin1 (NRG1) and RET. In LSQCC recurrent mutations of TP53, FGFR1, FGFR2, FGFR3, DDR2 and genes of the PI3K pathway have been detected, quantitative gene abnormalities of PTEN and CDKN2A. Developments in the characterization of lung cancer molecular abnormalities provided a strong rationale for new therapeutic options and for understanding the mechanisms of drug resistance. However, the complexity of lung cancer genomes is particularly high, as shown by deep-sequencing studies supporting the heterogeneity of lung tumors at cellular level, with sub-clones exhibiting different combinations of mutations. Molecular studies performed on lung tumors during treatment have shown the phenomenon of clonal evolution, thus supporting the occurrence of a temporal tumor heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–339 of 339
Shao, C., Sullivan, J. P., Girard, L., Augustyn, A., Yenerall, P., Rodriguez-Canales, J., Liu, H., Behrens, C., Shay, J. W., Wistuba, I. I., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3292 · Cited by 159
Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
Hussain, M., Rao, M., Humphries, A. E., Hong, J. A., Liu, F., Yang, M., Caragacianu, D., & Schrump, D. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2807 · Cited by 159
Semenova, E. A., Kwon, M.-C., Monkhorst, K., Song, J.-Y., Bhaskaran, R., Krijgsman, O., Kuilman, T., Peters, D., Buikhuisen, W. A., Smit, E. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.020 · Cited by 159
Faruki, H., Mayhew, G. M., Serody, J. S., Hayes, D. N., Perou, C. M., & Lai-Goldman, M. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.03.010 · Cited by 159
Cancer stem cells in lung cancer: Evidence and controversies
Alamgeer, M., Peacock, C. D., Matsui, W. H., Ganju, V., & Watkins, D. N. (2013) · Respirology · doi:10.1111/resp.12094 · Cited by 158
Duruisseaux, M., Besse, B., Cadranel, J., Pérol, M., Mennecier, B., Bigay-Game, L., Descourt, R., Dansin, E., Audigier-Valette, C., Moreau, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15746 · Cited by 158
Insertions and Deletions Target Lineage-Defining Genes in Human Cancers
Imielinski, M. B., Guo, G., & Meyerson, M. M. (2017) · Cell · doi:10.1016/j.cell.2016.12.025 · Cited by 157
Levina, V., Marrangoni, A., Wang, T., Parikh, S., Su, Y., Herberman, R., Lokshin, A., & Gorelik, E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1102 · Cited by 155
Izumchenko, E., Chang, X., Brait, M., Fertig, E. J., Kagohara, L. T., Bedi, A., Marchionni, L., Agrawal, N., Ravi, R. K., Jones, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9258 · Cited by 153
Salcido, C. D., Larochelle, A., Taylor, B. J., Dunbar, C. E., & Varticovski, L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605668 · Cited by 153
Ray, S., Chiba, N., Yao, C., Guan, X., McConnell, A. M., Brockway, B., Que, L. G., McQualter, J. L., & Stripp, B. R. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.09.010 · Cited by 149
Lin, C.-C., Shih, J.-Y., Yu, C.-J., Ho, C.-C., Liao, W.-Y., Lee, J.-H., Tsai, T.-H., Su, K.-Y., Hsieh, M.-S., Chang, Y.-L., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30480-0 · Cited by 145 · cited 1×
“These patients were evaluated by analysis of plasma tumoral DNA: patients without detectable EGFR-activating mutations in plasma before treatment had the best overall and post-progression survival; loss of the Thr790Met mutation, but presence of EGFR-activating mutations in plasma were associated with the shortest pro…”
MethodCurtis, S. J., Sinkevicius, K. W., Li, D., Lau, A. N., Roach, R. R., Zamponi, R., Woolfenden, A. E., Kirsch, D. G., Wong, K., & Kim, C. F. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.05.021 · Cited by 144
Camidge, D. R., Kim, D., Tiseo, M., Langer, C. J., Ahn, M., Shaw, A. T., Huber, R. M., Hochmair, M. J., Lee, K. H., Bazhenova, L. A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.5841 · Cited by 143
Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
Gutova, M., Najbauer, J., Gevorgyan, A., Metz, M. Z., Weng, Y., Shih, C.-C., & Aboody, K. S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000243 · Cited by 141
Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression
Lochmann, T. L., Floros, K. V., Naseri, M., Powell, K. M., Cook, W., March, R. J., Stein, G. T., Greninger, P., Maves, Y. K., Saunders, L. R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1606 · Cited by 134
Akunuru, S., Zhai, Q. J., & Zheng, Y. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.93 · Cited by 133
Regales, L., Balak, M. N., Gong, Y., Politi, K. A., Sawai, A., Le, C. H., Koutcher, J. A., Solit, D. B., Rosen, N. X., Zakowski, M. F., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000810 · Cited by 133
Dagogo‐Jack, I., Brannon, A. R., Ferris, L. A., Campbell, C. D., Lin, J. J., Schultz, K. R., Ackil, J., Stevens, S. E., Dardaei, L., Yoda, S., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00160 · Cited by 133
Voortman, J., Lee, J., Killian, J. K., Suuriniemi, M., Wang, Y., Lucchi, M., Smith, W. I., Meltzer, P. S., Wang, Y., & Giaccone, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008132107 · Cited by 132
Wang, C., Yin, R. H., Dai, J., Gu, Y., Cui, S., Ma, H., Zhang, Z., Huang, J., Qin, N., Jiang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04492-2 · Cited by 129
Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development
Lin, C., Song, H., Huang, C., Yao, E., Gacayan, R., Xu, S.-M., & Chuang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053817 · Cited by 128
Gao, Y., Zhang, W., Han, X., Li, F., Wang, X., Wang, R., Fang, Z., Tong, X., Yao, S., Li, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms5629 · Cited by 128
Serresi, M., Gargiulo, G., Proost, N., Siteur, B., Cesaroni, M., Koppens, M. A. J., Xie, H., Sutherland, K. D., Hulsman, D., Citterio, E., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.006 · Cited by 128
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Zhang, H., Fillmore Brainson, C., Koyama, S., Redig, A. J., Chen, T., Li, S., Gupta, M., Garcia-de-Alba, C., Paschini, M., Herter-Sprie, G. S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14922 · Cited by 127
Lung epithelial stem cells and their niches: Fgf10 takes center stage
Volckaert, T., & Langhe, S. D. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-8 · Cited by 126
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
Sharma, S. K., Pourat, J., Abdel-Atti, D., Carlin, S. D., Piersigilli, A., Bankovich, A. J., Gardner, E. E., Hamdy, O., Isse, K., Bheddah, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0299 · Cited by 125
Nakatsugawa, M., Takahashi, A., Hirohashi, Y., Torigoe, T., Inoda, S., Murase, M., Asanuma, H., Tamura, Y., Morita, R., Michifuri, Y., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.140 · Cited by 123
Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma
Sivakumar, S., Lucas, F. A. S., McDowell, T. L., Lang, W., Li, X., Fujimoto, J., Zhang, J. J., Futreal, P. A., Fukuoka, J., Yatabe, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1605 · Cited by 123
Chaft, J. E., Rusch, V., Ginsberg, M. S., Paik, P. K., Finley, D. J., Kris, M. G., Price, K. A. R., Azzoli, C. G., Fury, M. G., Riely, G. J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829923ec · Cited by 122
Maraver, A., Fernández-Marcos, P. J., Herranz, D., Cañamero, M., Muñoz‐Martín, M., Goméz-López, G., Mulero, F., Megı́as, D., Sänchez‐Carbayo, M., Shen, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.014 · Cited by 122
Tsao, M., Teuff, G. L., Shepherd, F. A., Landais, C., Hainaut, P. L., Filipits, M., Pirker, R., Chevalier, T. L., Graziano, S. L., Kratze, R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx003 · Cited by 122
SOX2 amplification is a common event in squamous cell carcinomas of different organ sites
Maier, S. H., Wilbertz, T., Braun, M., Scheble, V. J., Reischl, M., Mikut, R., Menon, R., Nikolov, P., Petersen, K., Beschorner, C., et al. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.11.010 · Cited by 121
Augert, A., Zhang, Q., Bates, B. M., Cui, M., Wang, X., Wildey, G. M., Dowlati, A., & MacPherson, D. P. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.12.011 · Cited by 121
Karlsson, A., Jönsson, M., Lauss, M., Brunnström, H., Jönsson, P., Borg, Å., Jönsson, G. B., Ringnér, M., Planck, M., & Staaf, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1087 · Cited by 120
Sanclemente, M., Francoz, S., Esteban-Burgos, L., Bousquet-Mur, E., Djurec, M., Lopez-Casas, P. P., Hidalgo, M., Guerra, C., Drosten, M., Musteanu, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.014 · Cited by 119 · cited 4×
“Using the KRASG12V/TRP53 mutations model, it was shown that: systemic ablation of MEK or ERK kinases in adult mice prevent tumor development but results in an unacceptable toxicity; ablation of c-RAF expression in advanced tumors results in tumor regression, with no development of resistance mechanisms [251].”
BackgroundMethodResultInfluentialThe Pivotal Role of IKKα in the Development of Spontaneous Lung Squamous Cell Carcinomas
Xiao, Z., Jiang, Q., Willette‐Brown, J., Xi, S., Zhu, F., Burkett, S. S., Back, T. C., Song, N., Datla, M., Sun, Z., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.009 · Cited by 119
Justilien, V., Regala, R. P., Tseng, I., Walsh, M. P., Batra, J., Radisky, E. S., Murray, N. R., & Fields, A. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035040 · Cited by 114
Regeneration of functional alveoli by adult human SOX9+ airway basal cell transplantation
Ma, Q., Ma, Y., Dai, X., Ren, T., Fu, Y., Liu, W., Han, Y., Wu, Y., Cheng, Y., Zhang, T., et al. (2018) · Protein & Cell · doi:10.1007/s13238-018-0506-y · Cited by 112
Qiu, X., Wang, Z., Li, Y., Miao, Y., Ren, Y., & Luan, Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.004 · Cited by 110
Wu, Q., Tian, Y., Zhang, J., Tong, X., Huang, H., Li, S., Zhao, H., Tang, Y., Yuan, C., Wang, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716589115 · Cited by 110
Progressive 3q Amplification Consistently Targets SOX2 in Preinvasive Squamous Lung Cancer
McCaughan, F. M., Pole, J. C. M., Bankier, A. T., Konfortov, B. A., Carroll, B., Falzon, M., Rabbitts, T. H., George, P. J., Dear, P. H., & Rabbitts, P. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0005oc · Cited by 109
Cutz, J., Guan, J., Bayani, J., Yoshimoto, M., Xue, H., Sutcliffe, M., English, J. C., Flint, J., LeRiche, J., Yee, J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0252 · Cited by 108
Zhang, Y., Xu, W., Guo, H., Zhang, Y., He, Y., Lee, S. H., Song, X., Li, X., Guo, Y., Zhao, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1633 · Cited by 108
Kumar, M., Allison, D. F., Baranova, N. N., Wamsley, J. J., Katz, A. J., Bekiranov, S., Jones, D. R., & Mayo, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068597 · Cited by 107
Treatment of Advanced Non–Small Cell Lung Cancer in 2018
Doroshow, D. B., & Herbst, R. S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5190 · Cited by 106
Zhang, W., Gao, Y., Li, F., Tong, X., Ren, Y., Han, X., Yao, S., Long, F., Yang, Z., Fan, H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3396 · Cited by 104
Sox2 Cooperates with Lkb1 Loss in a Mouse Model of Squamous Cell Lung Cancer
Mukhopadhyay, A., Berrett, K. C., Kc, U., Clair, P. M., Pop, S., Carr, S. R., Witt, B. L., & Oliver, T. G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.036 · Cited by 104
Adenosquamous Carcinoma of the Lung
Tochigi, N., Đačić, S., Nikiforova, M. N., Cieply, K. M., & Yousem, S. A. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp08iqzaogylfl · Cited by 104
Early Events in the Molecular Pathogenesis of Lung Cancer
Kadara, H. N., Scheet, P. A., Wistuba, I. I., & Spira, A. E. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0400 · Cited by 103
Winters, I. P., Chiou, S., Paulk, N. K., McFarland, C. D., Lalgudi, P. V., Ma, R. K., Lisowski, L., Connolly, A. J., Petrov, D. A., Kay, M. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01519-y · Cited by 102
Zhang, M. F., Mathur, A., Zhang, Y., Xi, S., Atay, S. M., Hong, J. A., Datrice, N., Upham, T. C., Kemp, C. D., Ripley, R. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3983 · Cited by 101
Shien, K., Toyooka, S., Ichimura, K., Soh, J., Furukawa, M., Maki, Y., Muraoka, T., Tanaka, N., Ueno, T., Asano, H., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.02.006 · Cited by 98
Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398
Datta, J., Damodaran, S., Parks, H., Ocrainiciuc, C., Miya, J., Yu, L., Gardner, E. P., Samorodnitsky, E., Wing, M. R., Bhatt, D., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-1010 · Cited by 98
Rapid target gene validation in complex cancer mouse models using re‐derived embryonic stem cells
Huijbers, I. J., Ali, R. B., Pritchard, C. E. J., Cozijnsen, M., Kwon, M., Proost, N., Song, J., de Vries, H., Badhai, J., Sutherland, K., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303297 · Cited by 94
Translating genomic information into clinical medicine: Lung cancer as a paradigm
Levy, M. A., Lovly, C. M., & Pao, W. J. (2012) · Genome Research · doi:10.1101/gr.131128.111 · Cited by 94
Regulation of human lung alveolar multipotent cells by a novel p38α MAPK/miR‐17‐92 axis
Oeztuerk-Winder, F., Guinot, A., Ochałek, A., & Ventura, J. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.192 · Cited by 92
Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer
Frederick, L. S., Matthews, J., Jamieson, L., Justilien, V., Thompson, E., Radisky, D., & Fields, A. (2008) · Oncogene · doi:10.1038/onc.2008.119 · Cited by 91
Zhang, X., Zhang, J., Li, M., Huang, X.-S., Yang, X., Zhong, W., Xie, L., Zhang, L., Zhou, M., Gavine, P. R., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-168 · Cited by 91
Regala, R. P., Davis, R. K., Kunz, A., Khoór, A., Leitges, M., & Fields, A. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2066 · Cited by 91
Wu, S., Yu, L., Wang, D., Zhou, L., Cheng, Z., Chai, D., Ma, L., & Tao, Y. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-535 · Cited by 90
Liu, L., Liu, J., Шао, Д., Deng, Q., Tang, H., Zu, L., Chen, X., Guo, F., Lin, Y., Mao, M., et al. (2017) · Cancer Science · doi:10.1111/cas.13410 · Cited by 90
Bjaanæs, M. M., Fleischer, T., Halvorsen, A. R., Daunay, A., Busato, F., Solberg, S. K., Jørgensen, L. H., Kure, E. H., Edvardsen, H., Børresen‐Dale, A., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.021 · Cited by 89
Nagathihalli, N. S., Massion, P. P., Gonzalez, A. L., Wang, L., & Datta, P. K. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0107 · Cited by 89
Clinical correlation of extensive-stage small-cell lung cancer genomics
Dowlati, A., Lipka, M. B., McColl, K. S., Dabir, S., Behtaj, M., Kresak, A. M., Miron, A., Yang, M., Sharma, N., Fu, P., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw005 · Cited by 88
Isolation and 3D expansion of multipotent Sox9+ mouse lung progenitors
Nichane, M., Javed, A., Vijayakumar, S., Ganesan, M., Ang, L. T., Kraus, P., Lufkin, T., Loh, K. M., & Lim, B. (2017) · Nature Methods · doi:10.1038/nmeth.4498 · Cited by 88
Lung cancer and lung stem cells - Strange bedfellows?
Giangreco, A., Groot, K., & Janes, S. (2007) · UCL Discovery (University College London) · Cited by 88
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
Jahchan, N. S., Lim, J. S., Bola, B. M., Morris, K. L., Seitz, G., Tran, K. Q. T., Xu, L., Trapani, F., Morrow, C. J., Cristea, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.021 · Cited by 87
Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma
Manceau, G., Letouzé, É., Guichard, C., Didelot, A., Cazes, A., Corté, H., Fabre, E., Pallier, K., Imbeaud, S., Pimpec‐Barthes, F. L., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27900 · Cited by 86
Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response
Sangodkar, J., Dhawan, N. S., Melville, H., Singh, V. J., Yuan, E., Rana, H. Q., Izadmehr, S., Farrington, C. C., Mazhar, S., Katz, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62058 · Cited by 86
The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2Preprint
Xu, X., Huang, L., Futtner, C. R., Schwab, B., Rampersad, R. R., Lu, Y., Sporn, T. A., Hogan, B. L. M., & Onaitis, M. W. (2014) · Genes & Development · doi:10.1101/gad.243717.114 · Cited by 85
Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
Asiedu, M. K., Thomas, C. F., Dong, J., Schulte, S. C., Khadka, P., Sun, Z., Kosari, F., Jen, J., Molina, J. R., Vasmatzis, G., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0252 · Cited by 85
Hellmann, M. D., Ott, P. A., Zugazagoitia, J., Ready, N., Hann, C. L., de Braud, F., Antonia, S. J., Ascierto, P. A., Moreno, V., Atmaca, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.8503 · Cited by 84
Wamsley, J. J., Kumar, M., Allison, D. F., Clift, S. H., Holzknecht, C. M., Szymura, S. J., Hoang, S. A., Xu, X., Moskaluk, C. A., Jones, D. R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2702 · Cited by 82
The Side Population in Human Lung Cancer Cell Line NCI-H460 Is Enriched in Stem-Like Cancer Cells
Shi, Y., Fu, X., Hua, Y.-Q., Yang, H., Lü, Y., & Wang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033358 · Cited by 82
Hou, S., Zhou, S., Qin, Z., Liu, Y., Han, X., Yao, S., & Ji, H. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.009 · Cited by 81
Ilié, M., Nunes, M., Blot, L., Hofman, V., Long-Mira, É., Butori, C., Selva, É., Merino‐Trigo, A., Vénissac, N., Mouroux, J., et al. (2014) · Cancer Medicine · doi:10.1002/cam4.357 · Cited by 80
Edelman, M. J., Redman, M. W., Albain, K. S., McGary, E. C., Rafique, N. M., Petro, D. P., Waqar, S. N., Minichiello, K., Miao, J., Papadimitrakopoulou, V. A., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.06.027 · Cited by 79
NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer
Wu, N., Jia, D., Ibrahim, A. H., Bachurski, C. J., Gronostajski, R. M., & MacPherson, D. P. (2016) · Oncotarget · doi:10.18632/oncotarget.11583 · Cited by 78
Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer
Becker‐Santos, D. D., Lonergan, K. M., Gronostajski, R. M., & Lam, W. L. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.027 · Cited by 78
Toschi, L., Finocchiaro, G., Nguyen, T. T., Skokan, M. C., Giordano, L., Gianoncelli, L., Perrino, M., Siracusano, L., Tommaso, L. D., Infante, M. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095303 · Cited by 75
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma
Tanaka, K., Hida, T., Oya, Y., Yoshida, T., Shimizu, J., Mizuno, T., Kuroda, H., Sakakura, N., Yoshimura, K., Horio, Y., et al. (2017) · Cancer · doi:10.1002/cncr.30539 · Cited by 74
A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer
Nolte, S. M., Venugopal, C., McFarlane, N., Morozova, O., Hallett, R. M., O’Farrell, E., Manoranjan, B., Murty, N. K., Klurfan, P., Kachur, E., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt022 · Cited by 73
The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma
Takada, K., Okamoto, T., Toyokawa, G., Kozuma, Y., Matsubara, T., Haratake, N., Akamine, T., Takamori, S., Katsura, M., Shoji, F., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.12.006 · Cited by 73
Turrell, F. K., Kerr, E. M., Gao, M., Thorpe, H., Doherty, G. J., Cridge, J., Shorthouse, D., Speed, A., Samarajiwa, S., Hall, B. A., et al. (2017) · Genes & Development · doi:10.1101/gad.298463.117 · Cited by 72
Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous
Chung, W., Daemen, A., Cheng, J. H., Long, J. E., Cooper, J. E., Wang, B.-E., Tran, C., Singh, M., Gnad, F., Modrusan, Z. D., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708391114 · Cited by 69
Lee, H. W., Lee, J.-I., Lee, S. J., Cho, H. J., Song, H. J., Jeong, D. E., Seo, Y. J., Shin, S. H., Joung, J., Kwon, Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1589 · Cited by 66
Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer
Doerr, F., George, J., Schmitt, A., Beleggia, F., Rehkämper, T., Hermann, S., Walter, V., Weber, J.-P. D., Thomas, R. K., Wittersheim, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15840-5 · Cited by 65
Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas
Wang, R., Pan, Y., Li, C., Zhang, H., Garfield, D. H., Li, Y., Ye, T., Hu, H., Luo, X., Li, H., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182a406d1 · Cited by 63
Kubo, T., Takigawa, N., Osawa, M., Harada, D., Ninomiya, T., Ochi, N., Ichihara, E., Yamane, H., Tanimoto, M., & Kiura, K. (2012) · Cancer Science · doi:10.1111/cas.12045 · Cited by 63
Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity
Akunuru, S., Palumbo, J. S., Zhai, Q. J., & Zheng, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016951 · Cited by 62
Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization
Sterlacci, W., Savic, S., Fiegl, M., Obermann, E. C., & Tzankov, A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000021 · Cited by 59
Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity
Brambilla, C., Laffaire, J., Lantuéjoul, S., Moro‐Sibilot, D., Nagy-Mignotte, H., Arbib, F., Toffart, A., Petel, F., Hainaut, P. L., Rousseaux, S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0459 · Cited by 59
Kim, H. R., Kang, H., Shim, H. S., Kim, E. Y., Kim, J., Kim, D. J., Lee, J. G., Lee, C. Y., Hong, M. H., Kim, S.-M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx098 · Cited by 58
Immunotherapy in surgically resectable non-small cell lung cancer
Owen, D. H., & Chaft, J. E. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.12.93 · Cited by 58
Cigarette Smoke Promotes Drug Resistance and Expansion of Cancer Stem Cell-Like Side Population
An, Y., Kiang, A., Lopez, J. P., Kuo, S. Z., Yu, M. A., Abhold, E. L., Chen, J. S., Wang‐Rodriguez, J., & Ongkeko, W. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047919 · Cited by 57
A paracrine network regulates the cross-talk between human lung stem cells and the stroma
Ruiz, E. J., Oeztuerk-Winder, F., & Ventura, J. (2014) · Nature Communications · doi:10.1038/ncomms4175 · Cited by 57
Mechanisms of Primary Drug Resistance in FGFR1 -Amplified Lung Cancer
Malchers, F., Ercanoglu, M. S., Schütte, D., Castiglione, R., Tischler, V., Michels, S. Y. F., Dahmen, I., Brägelmann, J., Menon, R., Heuckmann, J. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0478 · Cited by 57
Li, C., Gao, Z., Li, F., Li, X., Sun, Y., Wang, M., Li, D., Wang, R., Li, F., Fang, R., et al. (2015) · Scientific Reports · doi:10.1038/srep14237 · Cited by 56
Yang, H. J., Shi, J., Lin, D., Li, X., Zhao, C., Wang, Q., Zhang, L., Jiang, T., Zhao, S., Liu, X., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1243 · Cited by 53
Role of epigenetics in lung cancer heterogeneity and clinical implication
Dong, N., Shi, L., Wang, D. C., Chen, C., & Wang, X. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.029 · Cited by 51
Shi, X., Wu, S., Sun, J. H., Liu, Y., Zeng, X., & Liang, Z. (2017) · Scientific Reports · doi:10.1038/srep46209 · Cited by 50
Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer
Wang, X.-Y., Yu, H., Linnoila, R. I., Li, L., Li, D., Mo, B., Okano, H., Penalva, L. O. F., & Glazer, R. I. (2013) · Oncotarget · doi:10.18632/oncotarget.1034 · Cited by 48
Hu, H., Chen, H., Pan, Y., Li, Y., Wang, L., Wang, R., zhang, Y., Li, H., Ye, T., Zhang, Y., et al. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s58900 · Cited by 48
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
Fukazawa, T., Guo, M., Ishida, N., Yamatsuji, T., Takaoka, M., Yokota, E., Haisa, M., Miyake, N., Ikeda, T., Okui, T., et al. (2016) · Scientific Reports · doi:10.1038/srep20113 · Cited by 48
Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations
Bai, Y., Kim, J., Watters, J. M., Fang, B., Kinose, F., Song, L., Koomen, J. M., Teer, J. K., Fisher, K. J., Chen, Y. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0505 · Cited by 47
FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies
Weeden, C. E., Solomon, B., & Asselin-Labat, M.-L. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.49 · Cited by 46
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
Moro, M., Bertolini, G., Caserini, R., Borzi, C., Boeri, M., Fabbri, A., Leone, G., Gasparini, P., Galeone, C., Pelosi, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06912-7 · Cited by 44
Regala, R. P., Justilien, V., Walsh, M. P., Weems, C. R., Khoór, A., Murray, N. R., & Fields, A. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026439 · Cited by 42
Identification of Tumorigenic Cells in KrasG12D -Induced Lung Adenocarcinoma
Cho, H.-C., Lai, C.-Y., Shao, L., & Yu, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0903 · Cited by 39
Leong, T. L., Marini, K. D., Rossello, F. J., Jayasekara, S. N., Russell, P. A., Prodanovic, Z., Kumar, B., Ganju, V., Alamgeer, M., Irving, L. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106862 · Cited by 38
Genomics of Squamous Cell Lung Cancer
Rooney, M., Devarakonda, S. H. K., & Govindan, R. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0063 · Cited by 37
Fumarola, C., Cretella, D., Monica, S. L., Bonelli, M. A., Alfieri, R. R., Caffarra, C., Quaini, F., Madeddu, D., Falco, A., Cavazzoni, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19279 · Cited by 37
NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy
Xu, C., Buczkowski, K. A., Zhang, Y., Asahina, H., Beauchamp, E. M., Terai, H., Li, Y. Y., Meyerson, M. M., Wong, K., & Hammerman, P. S. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0077 · Cited by 33
Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers.
Chaft, J. E., Forde, P. M., Smith, K. N., Anagnostou, V., Cottrell, T. R., Taube, J. M., Rekhtman, N., Merghoub, T., Jones, D. R., Hellmann, M. D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.8508 · Cited by 33
Berezowska, S., Galván, J. A., Langer, R., Bubendorf, L., Savic, S., Gugger, M., Schmid, R. A., & Marti, T. M. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-2057-z · Cited by 32
Tiran, V., Lindenmann, J., Brčić, L., Heitzer, E., Stanzer, S., Ghaffari‐Tabrizi‐Wizsy, N., Stacher, E., Stoeger, H., Popper, H., Balić, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09929-0 · Cited by 32
Hong, S., Fang, W., Hu, Z., Zhou, T., Yan, Y., Qin, T., Tang, Y., Ma, Y., Zhao, Y., Xue, C., et al. (2014) · Scientific Reports · doi:10.1038/srep07268 · Cited by 29
Morphologic and Clinicopathologic Features of Lung Squamous Cell Carcinomas ExpressingSox2
Brčić, L., Sherer, C., Shuai, Y., Hornick, J. L., Chirieac, L. R., & Đačić, S. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcp05ttwqtwnltn · Cited by 29
Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung
Okamoto, T., Takada, K., Sato, S., Toyokawa, G., Tagawa, T., Shoji, F., Nakanishi, R., Oki, E., Koike, T., Nagahashi, M., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6401-1 · Cited by 27
Gadgeel, S. M., Ventimiglia, J., Kalemkerian, G. P., Fidler, M. J., Chen, W., Sukari, A. W., Halmos, B., Boerner, J. L., Wozniak, A. J., Galasso, C., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.8504 · Cited by 26
Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity
Wu, D., Pang, Y., Wilkerson, M. D., Wang, D., Hammerman, P. S., & Liu, J. S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.452 · Cited by 25 · cited 2×
“Studies with cell lines corresponding to the various subtypes indicate a differential sensitivity to various anti-tumor drugs; the secretory-type cell lines are significantly less sensitive to anticancer drugs [76].”
BackgroundGenetic alteration profiling of patients with resected squamous cell lung carcinomas
Tao, D., Han, X., Zhang, N., Lin, D., Wu, D., Zhu, X., Song, W., & Shi, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9096 · Cited by 25
Weeden, C. E., Holik, A. Z., Young, R. J., Ma, S. B., Garnier, J.-M., Fox, S. B., Antippa, P. N., Irving, L. B., Steinfort, D., Wright, G. M., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0174 · Cited by 25
A New Mouse Avatar Model of Non-Small Cell Lung Cancer
Russo, M. V., Faversani, A., Gatti, S., Ricca, D., GOBBO, A. D., Ferrero, S., Palleschi, A., Vaira, V., & Bòsari, S. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00052 · Cited by 24
Shi, X., Wu, H., Lu, J., Duan, H., Liu, X., & Liang, Z. (2016) · Scientific Reports · doi:10.1038/srep22297 · Cited by 24
KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients
Donnenberg, A. D., Zimmerlin, L., Landreneau, R. J., Luketich, J. D., & Donnenberg, V. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052885 · Cited by 21
Mather, J. P., Roberts, P. E., Pan, Z., Chen, F., Hooley, J., Young, P., Xu, X., Smith, D. H., Easton, A., Li, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079456 · Cited by 20 · cited 2×
“Important, while the cancer stem like cells coexpressed cytokeratin-5 and -7, the large majority of tumor cells generated in xenografts are either cytokeratin-5+ or cytokeratin-7+, with <10% of the cells remaining double positive [203].”
BackgroundLi, Q., Liu, F., Zhang, Y., Fu, L., Wang, C., Chen, X., Guan, S., & Meng, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9145 · Cited by 19
Role and regulation of Yap in KrasG12D-induced lung cancer
Mao, Y., Sun, S., & Irvine, K. D. (2017) · Oncotarget · doi:10.18632/oncotarget.22865 · Cited by 19
Zhao, B., Zhang, W., Yu, D., Xu, J., & Wei, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1387 · Cited by 18
He, M. Y., Liu, S., Kankanamalage, S. G., Borromeo, M. D., Girard, L., Gazdar, A. F., Minna, J. D., Johnson, J. E. B., & Cobb, M. H. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.01.004 · Cited by 18
Erdem, J. S., Skaug, V., Bakke, P. S., Gulsvik, A., Haugen, A., & Zienolddiny, S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2061-3 · Cited by 17
Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing
Ricordel, C., Lespagnol, A., Llamas‐Gutierrez, F., de Tayrac, M., Kerjouan, M., Fiévet, A., Hamdi‐Rozé, H., Aliouat, A., Desrues, B., Mosser, J., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.10.006 · Cited by 15
Chen, R., Ding, Z., Zhu, L., Lü, S., & Yu, Y. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.09.011 · Cited by 14
Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers
Lee, H. Y., Lee, S., Won, J., Lee, D. S., Kwon, N., Choi, S. M., Lee, J., Lee, C., Lee, S., Yim, J., et al. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.3.415 · Cited by 13
Kobayashi-Watanabe, N., Sato, A., Watanabe, T., Abe, T., Nakashima, C., Sueoka, E., Kimura, S. H., & Sueoka‐Aragane, N. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.05.017 · Cited by 12
Komarnitsky, P. B., Lee, H., Shah, M., Wong, S. L., Gauthier, S., Dziubinski, J., Osbaugh, S., & Zhang, F. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.tps8583 · Cited by 12
Cui, S., Dong, L., Qian, J., Lin, Y., & Jiang, L. (2017) · Journal of Cancer · doi:10.7150/jca.21842 · Cited by 12
Cited by
Cancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007
Fu, K., Xie, F., Wang, F., & Fu, L. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01391-4 · Cited by 397
He, J., Huang, Z., Han, L., Gong, Y., & Xie, C. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5270 · Cited by 314
The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
Cheng, Y. Y., Rath, E. M., Linton, A., Yuen, M. L., Takahashi, K., & Lee, K. (2020) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s186843 · Cited by 31
Metadata
- Authors
- Testa, U., Castelli, G., & Pelosi, E.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-07-27
- Volume
- 10
- Issue
- 8
- Pages
- 248
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2884192683
- Cited by
- 403
- References
- 339
- FWCI
- 28.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.